Feasibility & Patient Recruitment
D2V Clinical offers comprehensive site and enrollment feasibility services designed to facilitate successful clinical trials. Our expertise in feasibility assessments allows us to evaluate and identify optimal sites for your study, ensuring efficient patient enrollment and maximizing the chances of trial success. With a meticulous approach, we assess various factors including site capabilities, patient populations, regulatory considerations, and patient workflow. By leveraging our extensive network and industry experience, we provide sponsors with valuable insights and data-driven recommendations, enabling them to make informed decisions and optimize their trial design.
Our feasibility services include, but are not limited to:
Agency engagement
Our feasibility services include engaging with regulatory agencies to navigate the approval process, ensuring compliance and efficient communication throughout the study.
Site workflow
We meticulously evaluate site workflows, analyzing key logistical aspects such as patient recruitment, data collection, and study procedures to optimize efficiency, reduce potential bottlenecks, and enhance overall site performance.
Patient prevalence
Understanding patient prevalence is essential for accurate trial planning. Our feasibility services encompass thorough assessments of patient populations, allowing us to identify suitable sites with high recruitment potential and ensure a sufficient pool of eligible participants for your study.
Genomics
Harnessing the power of cutting-edge genomics technology, we integrate genomic data analysis into our research programs, providing valuable insights into disease mechanisms, biomarker identification, and personalized treatment approaches, driving advancements in precision medicine.
The China feasibility advantage: conduct feasibility in days, not months
D2V Clinical has established a close working relationship with one of the top healthcare record and payment processing enterprises in China. Utilize D2V’s access to real-world evidence in China to conduct feasibility and understand the design implications in a matter of days, not months. Let us bridge “the last mile” of feasibility and connect you with the right PIs.
9 months to regulatory startup
4X to 6X enrollment rate compared to the US
- Expertise in China CDE regulatory pathways
- Hospital-specific patient prevalence information for near-real-time feasibility
- Sponsor connection to enrolling GCP PIs in China
- US and China operations including medical, regulatory, clinical, biometrics
- Dual track PM communication: enrollment site local and sponsor local
D2V Clinical gives you access
300+
GCP sites/hospitals
400M+
patients accessed via China hospital prevalence data
1M+
PIs accessed via China hospital prevalence data